3-(Hydroxymethyl)-4-phenylbenzoic acid | 813424-00-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(Hydroxymethyl)-4-phenylbenzoic acid
• CAS: 813424-00-9
• 化学式: C₁₄H₁₂O₃
• 分子量: 228.247
• InChiKey: RCTNPESLHBWSEP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-(Hydroxymethyl)-4-phenylbenzoic acid 在 氯化亚砜 作用下， 以 苯 为溶剂， 生成 3-(Chloromethyl)-4-phenylbenzoic acid
  参考文献：
  名称：

  Design, synthesis and identification of novel colchicine-derived immunosuppressant

  摘要：

  Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.054
• 作为产物：
  描述：

  Methyl 2-(bromomethyl)[1,1a(2)-biphenyl]-4-carboxylate 在 水 作用下， 以 甲醇 为溶剂， 生成 3-(Hydroxymethyl)-4-phenylbenzoic acid 、 3-(Bromomethyl)-4-phenylbenzoic acid
  参考文献：
  名称：

  Design, synthesis and identification of novel colchicine-derived immunosuppressant

  摘要：

  Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.05.054

文献信息

• Benzamide derivative or salt thereof
  申请人：Kuramochi Takahiro

  公开号：US20070167444A1

  公开（公告）日：2007-07-19

  There is provided a compound having a capsaicin receptor VR1 inhibitory activity and useful as a therapeutic agent for various pains including inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder, and the like. A benzamide derivative or a salt thereof wherein a benzene ring is attached to a D ring (a monocyclic or bicyclic hydrocarbon ring or a monocyclic or bicyclic heteroaromatic ring) through an amide bond, the benzene ring is directly bonded to an E ring (a monocyclic or bicyclic hydrocarbon ring or a monocyclic or bicyclic heteroaromatic ring), and the benzene ring is further bonded to A (an amino moiety, a monocyclic or bicyclic heterocycle) through L (a lower alkylene).

  提供一种化合物，具有辣椒素受体VR1抑制活性，可用作治疗各种疼痛，包括炎症性疼痛和神经性疼痛、偏头痛、集群头痛、膀胱疾病（包括过度活动的膀胱）等的治疗剂。该化合物为苯甲酰胺衍生物或其盐，其中苯环通过酰胺键连接到D环（单环或双环碳氢环或单环或双环杂环芳香环），苯环直接连接到E环（单环或双环碳氢环或单环或双环杂环芳香环），苯环还通过L（较低的烷基）连接到A（氨基基团、单环或双环杂环）。
• BENZAMIDE DERIVATIVE OR SALT THEREOF
  申请人：Astellas Pharma Inc.

  公开号：EP1632477B1

  公开（公告）日：2017-03-01
• US7585878B2
  申请人：——

  公开号：US7585878B2

  公开（公告）日：2009-09-08
• US7855198B2
  申请人：——

  公开号：US7855198B2

  公开（公告）日：2010-12-21
• Design, synthesis and identification of novel colchicine-derived immunosuppressant
  作者：Dong-Jo Chang、Eun-Young Yoon、Geon-Bong Lee、Soon-Ok Kim、Wan-Joo Kim、Young-Myeong Kim、Jong-Wha Jung、Hongchan An、Young-Ger Suh

  DOI：10.1016/j.bmcl.2009.05.054

  日期：2009.8

  Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A. (C) 2009 Elsevier Ltd. All rights reserved.